Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Maternal obesity drives functional alterations in uterine NK cells
Sofie Perdu, … , Lauren DeLuca, Alexander G. Beristain
Sofie Perdu, … , Lauren DeLuca, Alexander G. Beristain
Published July 21, 2016
Citation Information: JCI Insight. 2016;1(11):e85560. https://doi.org/10.1172/jci.insight.85560.
View: Text | PDF
Research Article Immunology Reproductive biology

Maternal obesity drives functional alterations in uterine NK cells

  • Text
  • PDF
Abstract

Over one-fifth of North American women of childbearing age are obese, putting these women at risk for a variety of detrimental chronic diseases. In addition, obesity increases the risk for developing major complications during pregnancy. The mechanisms by which obesity contributes to pregnancy complications and loss remain unknown. Increasing evidence indicates that obesity results in major changes to adipose tissue immune cell composition and function; whether or not obesity also affects immune function in the uterus has not been explored. Here we investigated the effect of obesity on uterine natural killer (uNK) cells, which are essential for uterine artery remodeling and placental development. Using a cohort of obese or lean women, we found that obesity led to a significant reduction in uNK cell numbers accompanied with impaired uterine artery remodeling. uNK cells isolated from obese women had altered expression of genes and pathways associated with extracellular matrix remodeling and growth factor signaling. Specifically, uNK cells were hyper-responsive to PDGF, resulting in overexpression of decorin. Functionally, decorin strongly inhibited placental development by limiting trophoblast survival. Together, these findings establish a potentially new link between obesity and poor pregnancy outcomes, and indicate that obesity-driven changes to uterine-resident immune cells critically impair placental development.

Authors

Sofie Perdu, Barbara Castellana, Yoona Kim, Kathy Chan, Lauren DeLuca, Alexander G. Beristain

×

Figure 7

Decorin inhibits placental column outgrowth.

Options: View larger image (or click on image) Download as PowerPoint
Decorin inhibits placental column outgrowth.
(A) Representative flow cyt...
(A) Representative flow cytometry plots showing uterine NK (uNK) cell purity following 18 hours of culture. (B) Immunoblot showing decorin in uNK cell conditioned media (CM) from 3 distinct obese uNK cell cultures. Decidual tissue (Decidua) and control media (RPMI) function as positive and negative controls, respectively. Molecular weights (kDa) are shown to the left. (C) A schematic representation of the experimental procedure and timeline: CM = conditioned medium; DCN Ab = decorin-neutralizing antibody; d = day. (D) Quantification of extravillous trophoblast (EVT) column outgrowth in control (Con) and uNK cell CM–treated (uNK CM) placental explants in the presence or absence of a decorin-blocking antibody (DCN Ab). Outgrowth is calculated as the difference in column length (μm) at 48 and 0 hours. Explant assays were performed in duplicate using placental villi from 3 independent placentae (n = 12 to 14 columns per condition). (E) Representative images of placental villous explants cultured in control media, or in uNK CM with/without DCN Ab at 0 and 48 hours of culture. Inverted images of explants (invert) provide better contrast, where “villi” indicates placental villi, and hashed lines represent the EVT column base (white) and invasive extremity (black). Scale bars: 100 μm. Quantification (F) and representative images (G) of EVT column outgrowth following treatment with (n = 10 columns) or without (n = 10 columns) 20 μg/ml recombinant decorin (DCN). Placental explants were established from 4 independent placentae. (H) Representative images showing proliferative (Ki67+; red) and apoptotic (caspase-cleaved cytokeratin-18+ [K18+]; green) trophoblasts within EVT columns. The trophoblast marker keratin-7 (K7) is labeled white and nuclei are stained with DAPI (blue). Scale bars: 100 μm. The percentage of (I) proliferative and (J) apoptotic trophoblasts in DCN-untreated/treated cultures, calculated as the number of Ki67+ or cleaved cytokeratin-18+ cells into numbers of trophoblasts (K7+ cells). Results are presented as scatter plots with the indicated median values shown as horizontal lines. Statistical analyses between groups were performed using a nonparametric 2-tailed Mann-Whitney t test.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts